Asian Oncol Nurs.  2019 Jun;19(2):106-113. 10.5388/aon.2019.19.2.106.

Factors Influencing Compliance with Safety Guidelines of Anticancer Drugs Among Nurses in General Hospitals

• Jung J
• Park JY

• KMID: 2451736
• DOI: http://doi.org/10.5388/aon.2019.19.2.106

Abstract

PURPOSE
The purpose of this study was to investigate the level of compliance with the safety guidelines of anticancer drugs and identify the factors influencing compliance among general characteristics, knowledge of safety guidelines, self-efficacy, and workplace safety climate.
METHODS
This study used a cross-sectional descriptive design and 143 nurses who care for patients with cancer were surveyed. Data were collected from March 19 to March 31, 2018.
RESULTS
The subjects' average age was 29.2±5.1 years, and oncology nursing experience was 5.07±4.01 years. Workplace safety climate, age, work site, and oncology nursing experience had a significant influence on nurses' compliance with the safety guidelines of anticancer drugs. The explained variance for compliance was 23.5%.
CONCLUSION
The findings of this study indicate that the safety guidelines of anticancer drugs among nurses are expected to be better implemented by creating a safety-conscious environment. To maximize compliance nurses need to perform their tasks in an efficient manner, have institution-level active support, ready availability of personal protective equipment, appropriate education and a well-balanced workload.

Keyword

Antineoplastic agents; Safety; Guidelines; Compliance; Workplace

MeSH Terms

Antineoplastic Agents
Climate
Compliance*
Education
Hospitals, General*
Humans
Oncology Nursing
Personal Protective Equipment
Workplace
Antineoplastic Agents

Reference

1. Statistic Korea. Deaths and death rates by cause [Internet]. Available from. http://kosis.kr/common/meta_onedepth.jsp?vwcd=MT_OTITLE&listid=117_11744. [Accessed September 14, 2017].

2. Kim BK, Lee SL, Youn JH, Kim SM, Kim MH. Nurses’ knowledge, compliance and exposure experiences with cytotoxic drugs in a university hospital. Glob Health Nurs. 2016; 6:11–9.

3. Kyprianou M, Kapsou M, Raftopoulos V, Soteriades ES. Knowledge, attitudes and beliefs of Cypriot nurses on the handling of antineoplastic agents. Eur J Oncol Nurs. 2010; 14:278–82.

4. Pethran A, Schierl R, Hauff K, Grimm CH, Boos KS, Nowak D. Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health. 2003; 76:5–10.

5. Fransman W, Roeleveld N, Peelen S, de Kort W, Kromhout H, Heederik D. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes. Epidemiology. 2007; 18:112–9.

6. Spratley E, Johnson A, Sochalski J, Fritz M, Spencer W. Findings from the national sample survey of registered nurses [Internet]. Available from. http://bhpr.hrsa.gov/healthworkforce/rnsurveys/rnsurvey2000.pdf. [Accessed November 7, 2017].

7. U.S. Department of Health and Human Services. The registered nurse population: findings from the 2008 national sample survey of registered nurses. [Internet]. Available from. http://bhpr.hrsa.gov/healthworkforce/rnsurveys/rnsurveyfinal.pdf. [Accessed September 14, 2017].

8. Jacobson JO, Polovich M, McNiff KK, Lefebvre KB, Cummings C, Gal-ioto M, et al. American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol. 2009; 27:5469–75.

9. Choi JS, Kim YH, Gong SH, Jun MH, Park JS, Kim MJ. Level of knowledge and compliance on guidelines for safe handling of cytotoxic drugs by career and work units in clinical nurses. Clin Nurs Res. 2004; 9:6–17.

10. Yun JH, Park JY. Oncology nurses’ knowledge of safety guidelines and compliance with safe handling of antineoplastic agents in a tertiary hospital. Asian Oncol Nurs. 2016; 16:251–60.

11. Polovich M, Martin S. Nurses’ use of hazardous drug-handling precautions and awareness of national safety guidelines. Oncol Nurs Forum. 2011; 38:718–26.

12. Polovich M, Olsen M, LeFebvre KB. Chemotherapy and biotherapy guidelines and recommendations for practice. 4rd ed.Pittsburgh, PA: Oncology Nursing Society;2014.

13. Martin S, Larson E. Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncol Nurs Forum. 2003; 30:575–81.

14. Nixon S, Schulmeister L. Safe handling of hazardous drugs: are you protected? Clin J Oncol Nurs. 2009; 13:433–9.

15. Callahan A, Ames NJ, Manning ML, Touchton-Leonard K, Yang L, Wallen R. Factors influencing nurses’ use of hazardous drug safe-handling precautions. Oncol Nurs Forum. 2016; 43:342–9.

16. Polovich M, Clark PC. Factors influencing oncology nurses’ use of hazardous drug safe-handling precautions. Oncol Nurs Forum. 2012; 39:E299–309.

17. Geer LA, Curbow BA, Anna DH, Lees PS, Buckley TJ. Development of a questionnaire to assess worker knowledge, attitudes and perceptions underlying dermal exposure. Scand J Work Environ Health. 2006; 32:209–18.

18. Cooper MD, Phillips RA. Exploratory analysis of the safety climate and safety behavior relationship. J Safety Res. 2004; 35:497–512.

19. Suh YH, Oh HY. Knowledge, perception, safety climate, and compliance with hospital infection standard precautions among hospital nurses. J Korean Clin Nurs Res. 2010; 16:61–70.

20. National Institute for Occupational Safety and Health (US). Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. [Internet]. Available from. http://www.cdc.gov/niosh/docs/2004-165. [Access October 19, 2017].

21. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84:191–215.

22. Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers RW. The efficacy scale: construction and validation. Psychol Rep. 1982; 51:663–71.

23. Oh HS. Health promoting behaviors and quality of life of Korean women with arthritis. J Nurs Acad Soc. 1993; 23:617–30.

24. Gershon RR, Qureshi KA, Pogorzelska M, Rosen J, Gebbie KM, Brandt-Rauf PW, et al. Non-hospital based registered nurses and the risk of bloodborne pathogen exposure. Ind Health. 2007; 45:695–704.

25. Park JY, Kawk MK, Park HJ, Song SK, Yun JH, Cho HJ, et al. Korean oncology nursing society guidelines on oral chemotherapy. Asian Oncol Nurs. 2017; 17:201–12.

26. Neuss MN, Polovich M, McNiff K, Esper P, Gilmore TR, LeFebvre KB, et al. 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. J Oncol Pract. 2013; 9:5s–13s.